Shire changes leadership, still depends heavily on ADHD medicine sales

Shire P.L.C. will soon complete a change in leadership and is the subject of takeover speculation, but the drugmaker remains in the thick of the growing market for medicines used to treat attention deficit hyperactivity disorder.

Further reading